As of 2026-03-18, the Relative Valuation of Appili Therapeutics Inc (APLI.TO) is (0.22) CAD. This relative valuation is based on P/E multiples. With the latest stock price at 0.02 CAD, the upside of Appili Therapeutics Inc based on Relative Valuation is -1207.9%.
The range of the Relative Valuation is (0.28) - (0.16) CAD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 11.8x - 11.8x | 11.8x |
| Forward P/E multiples | 6.6x - 6.6x | 6.6x |
| Fair Price | (0.28) - (0.16) | (0.22) |
| Upside | -1521.0% - -894.8% | -1207.9% |
| Date | P/E |
| 2026-03-17 | -0.83 |
| 2026-03-10 | -0.83 |
| 2026-03-04 | -0.83 |
| 2026-03-03 | -0.83 |
| 2026-02-24 | -0.62 |
| 2026-02-20 | -0.83 |
| 2026-02-19 | -0.83 |
| 2026-02-18 | -0.83 |
| 2026-02-17 | -0.83 |
| 2026-02-13 | -0.83 |
| 2026-02-12 | -0.83 |
| 2026-02-11 | -1.04 |
| 2026-02-10 | -1.04 |
| 2026-02-09 | -0.83 |
| 2026-02-06 | -1.04 |
| 2026-02-05 | -0.83 |
| 2026-02-04 | -0.83 |
| 2026-02-03 | -1.04 |
| 2026-02-02 | -1.04 |
| 2026-01-30 | -1.04 |
| 2026-01-29 | -0.83 |
| 2026-01-23 | -0.83 |
| 2026-01-22 | -1.04 |
| 2026-01-16 | -0.83 |
| 2026-01-14 | -1.04 |
| 2026-01-13 | -0.83 |
| 2026-01-12 | -1.04 |
| 2026-01-09 | -0.83 |
| 2026-01-06 | -0.83 |
| 2025-12-29 | -1.04 |
| 2025-12-24 | -1.04 |
| 2025-12-23 | -1.04 |
| 2025-12-19 | -0.83 |